Abstract
Lung cancer is one of the most difficult cancers to cure, because early diagnosis and early curative treatment are more difficult than in gastrointestinal cancer. Diagnosis of gastric cancer, especially early cancer, has made great progress in Japan in the past 10 years due to the introduction of endoscopy. Only 26.5% of 809 patients with lung cancer were operated on during the past 10 years in Aichi Cancer Center Hospital, and curative resection of tumors was undertaken in only 16.5% of the total number of patients. Thus, it is apparent that chemotherapy and/or radiotherapy are important in the treatment of lung cancer. This paper presents a short review of the progress in the field of lung cancer chemotherapy in Japan.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alberto, P.: Remission rate, survival and prognostic factors in combination chemotherapy for bronchogenic carcinoma. Cancer Chemother. Rep. [Part 3] 4, 199 (1973)
Hansen, H. H., Muggia, F. M., Andrews, R., Selawry, O. S.: Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma. Cancer 30, 315 (1972)
Hornback, N. B., Einhorn, L., Shindnia, H., Joe, B. T., Krause, M., Furnas, B.: Oat cell carcinoma of the lung. Early treatment results of combination radiation therapy and chemotherapy. Cancer 37, 2658 (1976)
Hoshino, A.: Combination chemotherapy of mitomycin C, 5-fluorouracil and cytosine arabi-noside in L1210 mouse leukemia. In: The year book of cancer. Chicago: Year Book Medical 1970, p. 397
Ishioroshi, Y., Nishimura, M.: Combination chemotherapy with QFC in the lung cancer. Cancer Chemother. 4, 1335 (1977)
Kimura, I., et al.: Combination chemotherapy of bronchogenic carcinoma with FOBEM (5-fluorouraeil, vincristine, bleomycin, cyclophosphamide and mitomycin C) therapy. Lung Cancer 15, 289 (1975)
Kimura,, I., et al.: Combination chemotherapy with adriamycin, vincristine and ifosfamide in malignant mesenchymal tumors: A preliminary report. Cancer Chemother. 2, 661 (1975)
Kimura, I., et al.: Combination chemotherapy with cyclophosphamide, vincristine, methotrexate and procarbazine in the treatment of lung cancer. Cancer Chemother. 5, [Suppl.], 33 (1978)
Konno, A., Nakai, Y.: Lung cancer, chemotherapy in the internal medicine. Jpn. J. Cancer Clin. 23, 1093 (1977)
Kurita, S., Nishimura, M., Ogawa, M., Kamei, Y., Ariyoshi, Y., Murakami, M., Oyama, A., Sugiura, T., Kato, R., Ota, K.: Clinical studies on carbazilquinone in the treatment of malignant deseases. J. Jpn. Soc. Cancer Ther. 8, 119 (1973)
Miyamoto, T., Takabe, Y., Watanabe, M., Terasima, T.: Effectiveness of a sequential combination of bleomycin and mitomycin C on advanced cervical cancer. Cancer 41, 403 (1978)
Niitani, H.: Indication of anticancer agents for histological types of lung cancer. Nihon Kyobu Rinsho 37, 337 (1978)
Nishimura, M., et al.: A new combination therapy for lung cancer — combining multiple combination with small doses of radiotherapy. Cancer Chemother. 4, 1291(1977)
Oka, S., Sato, K., Kurita, K., Nakai, Y.: Treatment of lung cancer with bleomycin — the third report. Sci. Rep. Res. Inst. Tohoku Univ. [Med.] 19, 1 (1972)
Ota, K., et al.: Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man. Cancer Chemother. Rep., 56, 373 (1972)
Ota, K., Nishimura, M., Oyama, A., Morita, K., Mori, T., Kakei, M.: Combined radiation-chemotherapy treatment for carcinoma of the lung. Cancer Chemother. 1, 583 (1974)
Saijo, N., Nishiwaki, Y., Kawase, I., Kobayashi, T., Suzuki, A., Niitani, H.: Effect of ACNU on primary lung cancer, mesothelioma, and metastatic pulmonary tumors. Cancer Treat. Rep. 62, 139 (1978)
Selawry, O. S.: On chemotherapy of lung cancer. In: Lung cancer, natural history, prognosis, and therapy. Israel, L., Chahinian, A. P. New York, San Francisco, London: Academic 1976, p. 205
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ota, K., Nishimura, M. (1980). Present Status of Lung Cancer Chemotherapy in Japan. In: Carter, S.K., Sakurai, Y. (eds) New Anticancer Drugs. Recent Results in Cancer Research, vol 70. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81392-4_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-81392-4_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81394-8
Online ISBN: 978-3-642-81392-4
eBook Packages: Springer Book Archive